BeOne Medicines Ltd. (ONC) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
BeOne Medicines Ltd. (ONC) quarterly earnings & revenue
BeOne Medicines Ltd. (ONC) reported revenue of $1.51B for Q1 2026, up 35.5% year-over-year, with net income of $227.36M and diluted EPS of $25.35.
Over the last four reported quarters, BeOne Medicines Ltd. generated $5.74B in revenue and $513.02M in net income.
BeOne Medicines Ltd.'s next earnings report is scheduled for August 5, 2026 before market open; analysts estimate EPS of $1.57.
BeOne Medicines Ltd. quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $1.51B | +35.5% | $227.36M | $25.35 |
| Q4 2025 | $1.50B | +32.8% | $66.50M | $6.76 |
| Q3 2025 | $1.41B | +41.0% | $124.84M | $13.52 |
| Q2 2025 | $1.32B | +41.6% | $94.32M | $0.84 |
| Q1 2025 | $1.12B | +48.6% | $1.27M | $0.01 |
| Q4 2024 | $1.13B | +77.8% | $-151.88M | $-1.43 |
| Q3 2024 | $1.00B | +28.2% | $-121.35M | $-1.16 |
| Q2 2024 | $929.17M | +56.1% | $-120.41M | $-1.15 |
BeOne Medicines Ltd. (ONC) — frequently asked questions
When does BeOne Medicines Ltd. (ONC) report earnings next?
BeOne Medicines Ltd. is expected to report earnings on August 5, 2026 before market open. Analysts estimate EPS of $1.57.
What was ONC's revenue last quarter?
BeOne Medicines Ltd. reported revenue of $1.51B in Q1 2026, up 35.5% from the same quarter a year earlier.
What was ONC's EPS last quarter?
BeOne Medicines Ltd. reported diluted EPS of $25.35 in Q1 2026.
Is BeOne Medicines Ltd. profitable?
BeOne Medicines Ltd. is currently profitable, with $513.02M in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)